| Bioactivity | DOTA-NOC (DOTA-Nal3-octreotide) is a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5. DOTA-NOC can be used for labeling with various radiometals, and development of radiopeptide imaging[1]. |
| Invitro | 结合人生长抑素受体 SST 1-5 的亲和力数据 (IC50(μM))[1].Compound |
| Name | DOTA-NOC |
| CAS | 619300-53-7 |
| Sequence | {d-Phe}-Cys-Ala-{d-Trp}-Lys-Thr-Cys (Disulfide bridge: Cys2-Cys7) |
| Shortening | {d-Phe}-CA-{d-Trp}-KTC (Disulfide bridge: Cys2-Cys7) |
| Formula | C69H94N14O17S2 |
| Molar Mass | 1455.70 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wild D, et al. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1338-47. |
DOTA-NOC
CAS: 619300-53-7 F: C69H94N14O17S2 W: 1455.70
DOTA-NOC (DOTA-Nal3-octreotide) is a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5. DOTA-NOC can be
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.